BRIEF

on DIAGNOSTIC MEDICAL (EPA:ALDMS)

DMS Group: Revenue for the first half of 2024

Stock price chart of DIAGNOSTIC MEDICAL (EPA:ALDMS) showing fluctuations.

DMS Group announces a turnover of €22.9 million for the first half of 2024, an increase of 10% compared to 2023. Radiology represents 79% of the total with €18.1 million, up 9% . Bone densitometry reached €4.8 million, recording an increase of 14%.

Growth was driven by strong commercial momentum recorded in the second quarter, with an increase of 21% to reach €13 million. The company also signed a framework agreement in Denmark to supply mobile radiology equipment.

DMS Group continues to enrich its product range and anticipates positive synergies through the integration of Solutions for Tomorrow, with a significant impact on revenues from the fourth quarter. The company anticipates an improvement in the gross margin rate of 2 to 3% over the entire financial year.

The company's strategy is part of the Imaging 2027 plan, which targets a turnover of at least €70 million by 2027, with an EBITDA margin of 14%.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all DIAGNOSTIC MEDICAL news